BioCardia seeks regulatory approval in Japan.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioCardia seeks regulatory approval in Japan.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioCardia (United States)
company in San Carlos, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireBioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP® Cell Therapy in Ischemic Heart Failure SUNNYVALE, Calif., July 24, 2025 (GLOBE NEW